Clin Osteol 2025; 30(4): 203-208
Manažment osteoporózy u detíPřehledové články
- Detská klinika LF UK a NÚDCH Bratislava, Slovensko
Osteoporóza v detskom veku je zriedkavé, no závažné ochorenie charakterizované zníženou kostnou hustotou a zvýšenou náchylnosťou na zlomeniny. Primárne geneticky podmienené poruchy predstavujú len malú časť prípadov, zatiaľ čo až 98 % prípadov osteoporóz vzniká sekundárne v súvislosti s iným základným ochorením.
Klíčová slova: osteoporóza, deti, diagnostika, liečba, denzita kostného minerálu.
Management of osteoporosis in children
Osteoporosis in childhood is a rare but serious condition characterized by reduced bone density and increased susceptibility to fractures. Primary (genetically determined) disorders account for only a small proportion of cases, while up to 98% develop secondarily in association with another underlying disease. Diagnosis is based on clinical presentation, fracture history, and measurement of bone mineral density using Dual Energy X-ray Absorptiometry (DXA). In children, it is essential to adjust the Z-score for current height to ensure accurate interpretation of the results. Treatment requires a multidisciplinary approach focused on managing the underlying condition, optimizing nutrition, promoting physical activity, and, when indicated, administering medications that improve bone quality. This article provides an overview of current diagnostic and therapeutic recommendations, highlights differences compared to adult patients, and emphasizes the need for individualized management.
Keywords: osteoporosis, children, diagnostics, treatment, bone mineral density.
Zveřejněno: 1. prosinec 2025 Zobrazit citaci
Reference
- Clark EM. The epidemiology of fractures in otherwise healthy children. Curr Osteoporos Rep. 2014;12(3):272-8. doi: 10.1007/s11914-014-0227-y.
Přejít k původnímu zdroji... - Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. 2016;387(10028):1657-1671. doi: 10.1016/S0140-6736(15)00728-X. Přejít k původnímu zdroji...
- Zemel BS, Leonard MB, Kelly A, et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab. 2010;95(3):1265-1273. doi: 10.1210/jc.2009-2057. Přejít k původnímu zdroji...
- Crabtree NJ, Arabi A, Bachrach LK. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014;17(2):225-227. doi: 10.1016/j.jocd.2014.01.003. Přejít k původnímu zdroji...
- Bianchi ML. Osteoporosis in children and adolescents. Bone. 2007;41(4):486-495. doi:10.1210/jc.2007-0828. Přejít k původnímu zdroji...
- Gordon CM, Leonard MB and Zemel BS. 2013, Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom 2014;17:219-224.
- Official Pediatric Positions of the ISCD as updated in 2019.https://iscd.org/wp-content/uploads/2021/09/2019-Official-Positions-Pediatric-1.pdf.
- Ward LM. A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence. Frontiers in Endocrinology. 2024;14:1266986.
- Crabtree NJ, Chapman S, Högler W, et al. Vertebral fractures assessment in children: Evaluation of DXA imaging versus conventional spine radiography. Boneo 2017;97:168-174.
- Verdonk SJE,et al. Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1. Calcif Tissue Int. 2023 Aug;113(2):186-194. doi: 10.1007/s00223-023-01101-3. Přejít k původnímu zdroji...
- Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Rev Drug Discov. 2013;12(5):351-370.
- Sam JE, Dharmalingam M. Osteogenesis Imperfecta. Indian J Endocrinol Metab. 2017; 21(6):903-908. doi: 10.4103/ijem.IJEM_220_17. Přejít k původnímu zdroji...
- Hasegawa K. Osteogenesis imperfecta: pathogenesis, classification, and treatment. Clin Pediatr Endocrinol. 2025;34(3):152-161.
- Günay A., Turan S. Pediatric osteoporosis. An update Trends in Pediatrics 2024;5(4):105-115.
- Frost HM. Bone & quot;mass & quot; and the & quot;mechanostat & quot: a proposal. Anat Rec. 1987;219(1):1-9. doi: 10.1002/ar.1092190104. Přejít k původnímu zdroji...
- Ward LM, et al. Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study. J Bone Miner Res. 2018;33(8):1435-1443. doi: 10.1002/jbmr.3447. Přejít k původnímu zdroji...
- Alos N, Grant R, Ramsay T, et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol. 2012;1;30(22):2760-7. doi: 10.1200/JCO.2011.40.4830. Přejít k původnímu zdroji...
- Sakka SD, Cheung MS. Management of primary and secondary osteoporosis in children. Ther Adv Musculoskelet Dis. 2020 Nov 2;12:1759720X20969262. doi:10.1177/1759720X20969262. Přejít k původnímu zdroji...
- Bayer M. Osteogenesis imperfecta - state of art. Čes‑slov Pediatr. 2017;72(4):212-222.
- Kutílek Š, Plášilová I, Skálová S, et al. Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta. Acta Medica (Hradec Králové). 2021;64(3):187-192. doi:10.14712/18059694.2021.32. Přejít k původnímu zdroji...